BioCentury
ARTICLE | Finance

Asian leverage

Aslan taps Asian investors to move 3 compounds into Phase II by YE14

October 28, 2013 7:00 AM UTC

Aslan Pharmaceuticals Pte. Ltd. tapped into VCs with operational expertise in Asia for its latest round and plans to use the cash to build out its portfolio of in-licensed products.

Aslan raised $22 million this month in a series B led by new investor Cenova Ventures. New investors Morningside Group and XinChen Ventures joined existing investors BioVeda Capital and Sagamore Bioventures...